<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">From: Carol Blum <<a href="mailto:CBlum@COGR.edu">CBlum@COGR.edu</a>><br>
<br>
Additional information from NIH on October 11 that may be helpful. It is wise to follow NIH's advice: "<span style="background:yellow;mso-highlight:yellow">applicants are strongly encouraged
<b>not</b> to submit paper or electronic grant applications to NIH during the period of the lapse</span>."<br>
<br>
<b>From:</b> Used by OER for communications to grantees [<a href="mailto:NIH-ALERT@list.nih.gov">mailto:NIH-ALERT@list.nih.gov</a> ]
<b>On Behalf Of </b>NIH-Alert (NIH/OD)<br>
<b>Sent:</b> Friday, October 11, 2013 5:55 PM<br>
<b>To:</b> <a href="mailto:NIH-ALERT@list.nih.gov">NIH-ALERT@list.nih.gov</a><br>
<b>Subject:</b> Current Status of NIH Extramural Operations<br>
<br>
TO: NIH Extramural Community<br>
This is a brief communication to update the biomedical research community of the current status of extramural operations at NIH. The NIH continues to be shut down for all non-excepted activities. This means that the vast majority of NIH staff that oversee program,
review, and grants management are furloughed, NIH grants and contract submissions are not being processed, reviews are not occurring, and no awards are being made. As described in
<a href="http://grants.nih.gov/grants/guide/notice-files/NOT-OD-13-126.html">NOT-OD-13-126</a>, the Payment Management Systems remains operational and funds for most grants awarded before the shutdown can continue to be drawn down.
<br>
As the shutdown drags on, the challenge of reestablishing normal operations quickly is growing. Once the shutdown is over, NIH will need time to set new dates for grant and contract submissions, review meetings, conferences, and other activities that were scheduled
to happen during and immediately following the period of the shutdown. It will take us a few days after this is over to communicate our plans, so please bear with us.
<br>
<a name="_GoBack"></a>You can find the current guidance posted at grants.nih.gov. Once we reopen, additional information will be posted and published in the NIH Guide as quickly as we can make it available.<br>
All of us at NIH hope the current situation is resolved soon, but we don?t know when that will be.
<br>
We appreciate your patience as we go through this difficult experience together.
<br>
<br>
Sincerely,<br>
Sally Rockey, Ph.D.<br>
NIH Deputy Director for Extramural Research<o:p></o:p></p>
</div>
</body>
</html>